Zhejiang Nhu Co Ltd operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zhejiang Nhu Co Ltd with three other
companies in this sector in China:
Shandong Xinhua Pharmaceutical Company Limited
sales of 4.01 billion Chinese Renmimbi [US$610.63 million]
of which 44%
was Chemical Raw Medicine),
China Resources Double-Crane Pharmaceutical Company Limited
(5.49 billion Chinese Renmimbi [US$835.34 million]
of which 62%
was Non- transfusion), and
Apeloa Pharmaceutical Co Ltd
(4.77 billion Chinese Renmimbi [US$725.49 million]
of which 100%
was Health Care & Pharmaceutical).
Zhejiang Nhu Co Ltd reported sales of 4.70 billion Chinese Renmimbi (US$714.26 million)
December of 2016.
increase of 23.1%
versus 2015, when the company's sales were 3.82 billion Chinese Renmimbi.
Sales of Other, Main Operation saw an increase
33.0% in 2016, from
166.15 million Chinese Renmimbi to 220.92 million Chinese Renmimbi.